Relapsed or Refractory Large B-cell Lymphoma Clinical Trials in Salt Lake City, Utah

Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)